NCT02619812 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 30 days
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Group A: SBI + Placebo | 0 / 0 | 0 / 0 | Not reported / Not reported |
| Group B: Colesevelam + Placebo | 0 / 0 | 0 / 0 | Not reported / Not reported |
| Group C: Colesevelam + SBI | 0 / 1 | 1 / 1 | Not reported / Not reported |
| Group D: Double Placebo | 0 / 2 | 2 / 2 | Not reported / Not reported |
Serious adverse events
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 2
- num Events
- 2
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Stomach cramps
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Reproductive system and breast disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Testicular pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 1
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 2
- num Events
- 0
- term
- Abdominal bloating
Complete source fields
- event Groups
- description
- SBI 10 grams + placebo twice per day.
- id
- EG000
- other Num Affected
- 0
- other Num At Risk
- 0
- serious Num Affected
- 0
- serious Num At Risk
- 0
- title
- Group A: SBI + Placebo
- description
- Colesevelam 1.875 g + Placebo twice per day
- id
- EG001
- other Num Affected
- 0
- other Num At Risk
- 0
- serious Num Affected
- 0
- serious Num At Risk
- 0
- title
- Group B: Colesevelam + Placebo
- description
- Colesevelam 1.875 g + SBI 10 grams twice per day.
- id
- EG002
- other Num Affected
- 1
- other Num At Risk
- 1
- serious Num Affected
- 0
- serious Num At Risk
- 1
- title
- Group C: Colesevelam + SBI
- description
- Double Placebo: Double placebo twice per day (Subjects took a total of 4 packets of placebo and 12 capsules daily taken as 6 capsules twice a day by mouth and two packets of placebo twice a day mixed with water or blended with certain foods).
- id
- EG003
- other Num Affected
- 2
- other Num At Risk
- 2
- serious Num Affected
- 0
- serious Num At Risk
- 2
- title
- Group D: Double Placebo
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 2
- num Events
- 2
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Stomach cramps
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Reproductive system and breast disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 2
- num Events
- 1
- term
- Testicular pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 0
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 1
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 2
- num Events
- 0
- term
- Abdominal bloating
- time Frame
- 30 days
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle